11-298562-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001025295.3(IFITM5):c.338G>A(p.Arg113Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000986 in 1,613,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001025295.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFITM5 | NM_001025295.3 | c.338G>A | p.Arg113Gln | missense_variant | 2/2 | ENST00000382614.2 | NP_001020466.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IFITM5 | ENST00000382614.2 | c.338G>A | p.Arg113Gln | missense_variant | 2/2 | 1 | NM_001025295.3 | ENSP00000372059.2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000920 AC: 23AN: 249874Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135500
GnomAD4 exome AF: 0.0000910 AC: 133AN: 1460946Hom.: 0 Cov.: 31 AF XY: 0.0000991 AC XY: 72AN XY: 726760
GnomAD4 genome AF: 0.000171 AC: 26AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74498
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.338G>A (p.R113Q) alteration is located in exon 2 (coding exon 2) of the IFITM5 gene. This alteration results from a G to A substitution at nucleotide position 338, causing the arginine (R) at amino acid position 113 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at